LUCKY 18 LTD
Company number 13113682 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
LUCKY 18 LTD - Analysis Report
Company Number: 13113682
Analysis Date: 2025-07-20 13:09 UTC
Financial Health Assessment: LUCKY 18 LTD (as of 31 January 2024)
1. Financial Health Score: C (Moderate Concern)
Explanation:
The company shows a recent turnaround from a serious liquidity crisis in 2023, moving to a positive net current asset position in 2024. However, the very low absolute asset base and small equity suggest a fragile financial state, with risks still present. The score reflects the improvement but cautions that the business is still in a delicate recovery phase.
2. Key Vital Signs
| Metric | 2024 | 2023 | Interpretation |
|---|---|---|---|
| Current Assets | £12,638 | £212 | Healthy increase in liquid assets; vital sign of improved cash flow or receivables management. |
| Current Liabilities | £7,967 | £61,565 | Significant reduction in short-term debts; symptom of effective liability management or debt restructuring. |
| Net Current Assets | £4,671 | -£61,353 | Positive working capital in 2024 vs. large deficit in 2023; indicates better short-term financial health. |
| Net Assets (Shareholders’ Funds) | £4,671 | -£61,353 | From negative equity to positive suggests recapitalization or retained earnings recovery. |
| Share Capital | £10 | £10 | Minimal capital base; company is micro-sized with limited equity buffer. |
| Employees (Average) | 6 | 7 | Slight reduction in workforce, possibly cost control measure. |
Interpretation of Vital Signs:
The company was previously showing "symptoms of distress" with large current liabilities far exceeding current assets in 2023, indicating liquidity issues and potential insolvency risk. The 2024 figures show a "healthy cash flow" recovery with current assets now exceeding liabilities, enabling better ability to meet short-term obligations. However, the total net assets and equity remain very modest, indicating limited financial cushion.
3. Diagnosis
Liquidity and Solvency: The company has moved from a precarious position with significant negative working capital in 2023 to a positive net current asset position in 2024. This is a positive sign akin to a patient recovering from acute distress. The dramatic reduction in current liabilities suggests successful negotiations with creditors, debt repayments, or restructuring.
Capital Structure: The minimal share capital (£10) and relatively low net assets (£4,671) mean the company is still vulnerable to financial shocks. There is limited equity to absorb losses or fund growth, much like a patient with low immunity.
Operational Scale: As a micro-entity with around 6 employees, the company is small and likely highly sensitive to market changes and operational risks. The slight decrease in staff may represent cost-cutting to stabilize finances.
Business Activity: The company operates in varied sectors—unlicensed carrier services, agents in goods sale, and women's outerwear manufacturing—indicating a diversified but possibly unfocused business model which can strain resources.
Governance: Two directors are in place, with significant control held by Mr. Jigar Ratilal (75-100%). This concentration of control can be a strength for quick decisions but also a risk if oversight is limited.
4. Recommendations
Cash Flow Management: Maintain rigorous monitoring of cash inflows and outflows to ensure liquidity remains positive. Establish cash flow forecasting and contingency reserves to avoid recurrence of past distress symptoms.
Debt Management: Continue to manage liabilities prudently. Explore opportunities for refinancing or renegotiating payment terms to sustain the improved working capital.
Equity Strengthening: Consider increasing share capital or retaining more earnings to build a stronger equity base, providing a buffer against future losses or economic downturns.
Operational Focus: Given the multiple SIC codes, assess the core profitable activities and consider focusing resources on the most viable business lines to improve margins and operational efficiency.
Governance and Controls: Implement strong internal controls and perhaps diversify management oversight to reduce risks associated with concentrated control.
Growth and Investment: With the improved financial position, cautiously explore growth opportunities but avoid overextending resources or taking on excessive debt.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.